Vivosim Labs Inc (VIVS) Return on Investment ROI from the first quarter of 2026 to first quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Vivosim Labs Inc   (NASDAQ: VIVS)


Vivosim Labs Inc's ROI from its first quarter of 2026 to the first quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Vivosim Labs Inc's ROI in the first quarter of 2026?
Vivosim Labs Inc recorded a cumulative net loss of $-12 million during 12 months ending in the first quarter of 2026, resulting in a negative return on investment (ROI) of -199.77%.

Within the Healthcare sector 478 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2026 from 0 to 3592.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
I. Quarter		 (Mar 31 2026)
IV. Quarter		 (Dec 31 2025)
III. Quarter		 (Sep 30 2025)
II. Quarter		 (Jun 30 2025)
I. Quarter
Y / Y Investment Change TTM -16.48 % 19.9 % 87.42 % -1.32 % -22.43 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 2 5 11 7 10
Return On Investment (TTM) -199.77 % -169.92 % -12.62 % -24.42 % -26.87 %
VIVS's Overall Ranking # 3592 # 0 # 0 # 0 # 0
Seq. Investment Change TTM -24.19 % -16.23 % 19.78 % 9.79 % 8.83 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -12 -14 -1 -2 -2

VIVS Company Profile >> Back to VIVS Roi Comparisons >> See Annual VIVS Return On Investment



Return On Investment VIVS's Ranking
Within: No.
Industry # 74
Sector # 479
Overall # 3592

Return On Investment Statistics
High Average Low
216.09 %
-126.46 %
-1550.4 %
(Jun 30 2013)   (Jun 30 2012)







Financial Statements
Vivosim Labs Inc's I. Quarter Investments $ 2 Millions VIVS's Balance sheet
Vivosim Labs Inc's I. Quarter Income $ -1 Millions Quarterly VIVS's Income Statement
VIVS's Income by Division See VIVS's Income by Division


VIVS Annual Return On Investment (Mar 31 2026)
2026		 (Mar 31 2025)
2025		 (Mar 31 2024)
2024		 (Mar 31 2023)
2023		 (Mar 31 2022)
2022
Total Investments in Millions 5 11 4 17 32
Y / Y Investment Growth -57.84 % 143.11 % -73.03 % -47.85 % -18.58 %
Net Income in Millions -14 -2 -15 -17 -11
Y / Y Net Income Growth - - - - -
Annual Return On Investment -300.87 % -22.8 % -326.82 % -103.71 % -35.87 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
VIVS's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for VIVS's Competitors
Subscribers only: Roi for Vivosim Labs Inc's Suppliers
Subscribers only: Return On Investment for VIVS's Customers

Other Ratios
VIVS's Roa VIVS's Inventory Turnover Ratio VIVS's Growth Rates VIVS's Dividend Statistics
VIVS's Profitability Ratios VIVS's Asset Turnover Ratio VIVS's Dividend Growth
VIVS's Roe VIVS's Valuation Ratios VIVS's Financial Strength Ratios VIVS's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-26T06:52:06+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.